论文部分内容阅读
目的探讨探讨治疗儿童急性病毒性心肌炎的最佳方案。方法三组患儿均接受基础治疗。A组给予1,6-二磷酸果糖静脉点滴;B组给予黄芪注射液静脉点滴;C组给予1,6-二磷酸果糖,黄芪注射液静脉点滴。疗程均为2周。治疗期间观察临床症状、体征的改善,复查心电图,治疗前后各检测1次肌酸磷酸激酶同工酶、肌钙蛋白。结果 C组总有效率明显高于A、B组,C组与A、B两组比较有显著性差异(P<0.05)。所有病例治疗过程中均未发生不良反应。结论黄芪注射液联合1,6-二磷酸果糖是治疗儿童急性病毒性心肌炎经济有效的方案。
Objective To explore the best treatment of children with acute viral myocarditis. Methods Three groups of children received basic treatment. A group given intravenous fructose 1,6 - diphosphate intravenous drip; B group given Astragalus injection intravenous; C group given fructose 1,6 diphosphate, Astragalus injection intravenous drip. The course of treatment is 2 weeks. Observation of clinical symptoms during treatment, signs of improvement, review of ECG, before and after treatment for each test creatine phosphokinase isoenzyme, troponin. Results The total effective rate in group C was significantly higher than that in group A and B, and there was a significant difference between group C and groups A and B (P <0.05). No adverse reactions occurred during the treatment of all cases. Conclusion Astragalus injection combined with fructose-1,6-diphosphate is a cost-effective treatment for acute viral myocarditis in children.